Healthcare research
in Medicine, patients and the law (sixth edition)
Abstract only
Log-in for full text

You are not authenticated to view the full text of this chapter or article.

manchesterhive requires a subscription or purchase to access the full text of books or journals - to see content that you/your institution should have access to, please log in through your library system or with your personal username and password.

If you are authenticated and think you should have access to this title, please contact your librarian.

Non-subscribers can freely search the site, view abstracts/extracts and download selected front and end matter. 

Institutions can purchase access to individual titles; please contact manchesterhive@manchester.ac.uk for pricing options.

ACCESS TOKENS

If you have an access token for this content, you can redeem this via the link below:

Redeem token

This chapter focuses on the regulation of Healthcare Research. If medicine is to progress to combat cancer and continue the battle against diseases such as diabetes and multiple sclerosis, new drugs and procedures must be subject to trials. But patients must not be used as a means to an end. We consider the role of Research Ethics Committees in balancing the risks and burdens of research and set out the law relating to consent, children, those lacking capacity and emergency research. Compensation is considered and we consider the legal response to research misconduct.

Metrics

All Time Past Year Past 30 Days
Abstract Views 20 20 6
Full Text Views 0 0 0
PDF Downloads 2 2 2